References

 

Ahlquist-Cleveland A, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, Lockhart SR, Park BJ 2015 Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One 30;10(3):e0120452

 

Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, Cuenca-Estrella M, Gómez-López A, Boekhout 2012 Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol 50: 3641-3651

 

Centers for Disease Control website for Candida auris. https://www.cdc.gov/fungal/diseases/candidiasis/candida-auris.html

 

Chiller T 2017 The unexpected and troubling rise of Candida auris. https://www.medscape.com/viewarticle/884470

 

Daniel H-M, Lachance M-A, Kurtzman CP 2014 On the reclassification of species assigned to Candida and other anamorphic ascomycetous yeast genera based on phylogenetic circumscription. Anton van Leeuwenhoek 106:67-84

Delaloye J, Calandra T 2014 Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5:161-169

Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A 2015 Multidrug-Resistant Candida auris misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53:1823-1830

 

Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M 2017 The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of scy-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61(5). pii: e02396-16

 

Lu Y, Su C, Liu H  2014  Candida albicans hyphal initiation and elongation. Trends Microbiol 22:707-714

 

McKay LI, Cidlowski JA, Corticosteroids in the treatment of neoplasms in Kufe DW et al. (eds.), 2003 Holland-Frei Cancer Medicine, 6^th ed. BC Decker Publishers.

 

Merseguel KB , Nishikaku AS , Rodrigues AM , Padovan AC , e Ferreira RC, de Azevedo Melo AS, Briones MR, Colombo AL 2015 Genetic diversity of medically important and emerging Candida species causing invasive infection. BMC Infect Dis 15: 57

 

Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, Hewitt C, Simner PJ, Carroll KC, Hayden RT, Zhang SX 2017 Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol 55:638-640

 

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD 2016 Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis  62:e1-e50

 

Poetker DM, DD Reh 2010 A Comprehensive Review of the Adverse Effects of Systemic Corticosteroids. Otolaryngologic Clinics North America  43: 753-768 

 

Turner SA, Butler G 2014 The Candida pathogenic species complex. Cold Spring Harb Perspect Med. Sep 2;4(9):a019778.